Hüseyin ASLAN, Süheyl HAYTOĞLU, Gökhan KURAN, Özge ÖZALP YÜREĞİR, Sevcan TUĞ BOZDOĞAN

IL-1RN VNTR, IL-2(-330), and IL-4 VNTR gene polymorphisms in patients with chronic rhinosinusitis with sinonasal polyposis

Background/aim: Sinonasal polyposis is a complex chronic disease displaying contributions from multiple genetic and environmentalfactors. In this study, we analyzed possible genetic factors that increase susceptibility to this widespread inflammatory disease.Materials and methods: A total of 176 adult patients, including 78 patients with sinonasal polyposis and 98 healthy controls, wereanalyzed for IL-1RN VNTR, IL-2(-330), and IL-4 VNTR gene polymorphisms using polymerase chain reaction and enzyme restriction.Results: IL-1RN and IL-4 VNTR polymorphisms were notably associated with sinonasal polyposis (P = 0.0001 and P = 0.036,respectively); however, regarding the IL-2(-330) gene polymorphism, no significant difference was shown between the patient andcontrol groups (P = 0.235).Conclusions: Our study indicates that the RN2 allele of IL-1RN and the RP1 allele of IL-4 might be risk factors for developing sinonasalpolyposis.

PDF

___

1. Fokkens WJ, Lund VJ, Mullol J, Bachert C, Alobid I et al. European position paper on rhinosinusitis and nasal polyps. Rhinology 2012; Mar 50(1): 1-12.
2. Sousa H, Breda E, Santos AM, Catarino R, Pinto D et al. IL1RN VNTR polymorphism as a susceptibility marker for nasopharyngeal carcinoma in Portugal. Archives of Oral Biology 2013; 58(8): 1040-1046.
3. Al-Tahhan M, Etewa RL, El Behery MM. Association between circulating interleukin-1 beta (IL-1b) levels and IL-1b C-511 T polymorphism with cervical cancer risk in Egyptian women. Molecular and Cellular Biochemistry 2011; 353: 159-165.
4. Tarlow JK, Blakemore AI, Lennard A, Solari R, Hughes HN et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Human Genetics 1993; 91: 403-404.
5. Gohlke H, Illig T, Bahnweg M, Klopp N, Andre E, Altmuller J et al. Association of the interleukin-1 receptor antagonist gene with asthma. American Journal of Respiratory Critical Care Medicine 2004; 169(11): 1217-1223.
6. Haukim N, Bidwell JL, Smith AJ, Keen LJ, Gallagher G et al. Cytokine gene polymorphism in human disease: on-line databases. Genes and Immunity 2002; 3(6): 313-330.
7. Paul WE, Seder RA. Lymphocyte responses and cytokines. Cell 1994; 76(2): 241-251.
8. Degrave W, Tavernier J, Duerinck F, Plaetinck G, Devos R et al. Cloning and structure of the human Interleukin 2 chromosomal gene. EMBO Journal 1983; 2(12): 2349-2353.
9. John S, Turner D, Donn R, Sinnott P, Worthington J et al. Two novel biallelic polymorphisms in the IL-2 gene. European Journal of Immunogenetics 1998; 25(6): 419-420.
10. Coffman RL, Ohara J, Bond MW, Carty J, Zlotnik A et al. B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. The Journal of Immunology 1986; 136(12): 4538-4541.
11. Del Prete G, Maggi E, Parronchi P, Chretien I, Tiri A et al. IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants. The Journal of Immunology 1988; 140(12): 4193-4198.
12. Peric A, Vojvodic D, Vukomanovic-Durdevic B, Baletic N. Eosinophilic inflammation in allergic rhinitis and nasal polyposis. Archives of Industrial Hygiene Toxicology 2011; 62(4): 341-348.
13. Kayar NA, Alptekin NÖ, Erdal ME. Interleukin-1 receptor antagonist gene polymorphism, adverse pregnancy outcome and periodontitis in Turkish women. Archives of Oral Biology 2015; 60(12): 1777-1783.
14. Moorchung N, Vasudevan B, Chatterjee M, Mani NS, Grewal RS. Interleukin-1 gene polymorphisms and their relation with NFκB expression and histopathological features in psoriasis. Indian Journal of Dermatology 2015; 60(5): 432-438.
15. Kamenarska Z, Dzhebir G, Hristova M, Savov A, Vinkov A et al. IL-1RN VNTR polymorphism in adult dermatomyositis and systemic lupus erythematosus. Dermatology Research and Practice. 2014; 2014953597. doi: 10.1155/2014/953597
16. Kulmambetova GN, Imanbekova MK, Logvinenko AA, Sukashev AT, Filipenko ML et al. Association of cytokine gene polymorphisms with gastritis in a Kazakh population. Asian Pacific Journal of Cancer Prevention 2014; 15(18): 7763-7768.
17. Ben Nejma M, Zaabar I, Zaafrane F, Thabet S, Mechri A et al. A gender-specific association of interleukin 1 receptor antagonist polymorphism with schizophrenia susceptibility. Acta Neuropsychiatric 2013; 25(6): 349-355.
18. Aureli A, Sebastiani P, Del Beato T, Marimpietri AE, Graziani A et al. Involvement of IL-6 and IL-1 receptor antagonist on intellectual disability. Immunology Letters 2014; 162: 124-131.
19. Wu S, Hu G, Chen J, Xie G. Int J Interleukin 1β and interleukin 1 receptor antagonist gene polymorphisms and cervical cancer: a meta-analysis. International Journal of Gynecological Cancer 2014; 24(6): 984-990.
20. Zeyrek D, Demir E, Alpman A, Ozkinay F, Gulen F et al. Association of interleukin-1beta and interleukin-1 receptor antagonist gene polymorphisms in Turkish children with atopic asthma. Allergy and Asthma Proceedings 2008; 29(5): 468-474.
21. Pillay V, Gaillard MC, Halkas A, Song E, Dewar JB. Differences in the genotypes and plasma concentrations of the INTERLEUKIN-1 receptor antagonist in black and white South African asthmatics and control subjects. Cytokine 2000; 12(6): 819-821.
22. Birbian N, Singh J, Jindal SK. High risk association of IL-1 receptor antagonist (IL-1RN) VNTR polymorphism with asthma in a North Indian population: a pilot study. Cytokine 2013; 62(3): 389-394.
23. Mao XQ, Kawai M, Yamashita T, Enomoto T, Dake Y et al. Imbalance production between interleukin-1beta (IL-1beta) and IL-1 receptor antagonist (IL-1Ra) in bronchial asthma. Biochemical and Biophysical Research Communications 2000; 276(2): 607-612.
24. Cheng YK, Lin CD, Chang WC, Hwang GY, Tsai SW et al. Increased prevalence of interleukin-1 receptor antagonist gene polymorphism in patients with chronic rhinosinusitis. Archives of Otolaryngology–Head and Neck Surgery 2006; 132(3): 285-290.
25. Zhang N, Van Zele T, Perez-Novo C, Van Bruaene N, Holtappels G et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease. Journal of Allergy and Clinical Immunology 2008; 122(5): 961-968.
26. Sobjanek M, Zabłotna M, Bień E, Gleń J, SokołowskaWojdyło M et al. Clinical significance of IL-2 and IL-10 gene polymorphisms and serum levels in patients with basal-cell carcinoma. Biomarkers in Medicine 2016; 10(2): 185-195.
27. Liang C, DU W, Dong Q, Liu X, Li W et al. Expression levels and genetic polymorphisms of interleukin-2 and interleukin-10 as biomarkers of Graves’ disease. Experimental Therapeutic Medicine 2015; 9(3): 925-930.
28. Bei CH, Bai H, Yu HP, Yang Y, Liang QQ et al. Combined effects of six cytokine gene polymorphisms and SNP-SNP interactions on hepatocellular carcinoma risk in Southern Guangxi, China. Asian Pacific Journal of Cancer Prevention 2014; 15(16): 6961- 6967.
29. Sayad A, Movafagh A. The association of -330 interleukin-2 gene polymorphism with its plasma concentration in Iranian multiple sclerosis patients. Scientifica (Cairo) 2014; 2014: 724653. doi: 10.1155/2014/72465
30. Yücel A, Dilek K, Saba D, Ozçimen AA, Yurtkuran M et al. Interleukin-2 gene polymorphism in Turkish patients with Behçet’s disease and its association with ocular involvement. International Journal of Immunogenetics 2013; 40(5): 349-355.
31. Wei YS, Lan Y, Zhang L, Wang JC. Association of the interleukin-2 polymorphisms with interleukin-2 serum levels and risk of nasopharyngeal carcinoma. DNA and Cell Biology 2010; 29(7): 363-368.
32. Berković MC, Jokić M, Marout J, Radosević S, Zjacić-Rotkvić V et al. IL-2 -330 T/G SNP and serum values: potential new tumor markers in neuroendocrine tumors of the gastrointestinal tract and pancreas (GEP-NETs). Journal of Molecular Medicine 2010; 88(4): 423-429.
33. Xiaomin L, Fenglin C, Jianmin H, Yuzhi S, Binsheng G et al. Correlation between genetic polymorphism of cytokine genes, plasma protein levels and bronchial asthma in the Han people in northern China. Journal of Asthma 2008; 45(7): 583-589.
34. Trajkov D, Mirkovska-Stojkovikj J, Petlichkovski A, Strezova A, Efinska-Mladenovska O et al. Association of cytokine gene polymorphisms with chronic obstructive pulmonary disease in Macedonians. Iranian Journal of Allergy Asthma and Immunology 2009; 8(1): 31-42.
35. Movahedi M, Mahdaviani SA, Rezaei N, Moradi B, Dorkhosh S et al. IL-10, TGF-beta, IL-2, IL-12, and IFN-gamma cytokine gene polymorphisms in asthma. Journal of Asthma 2008; 45(9): 790-794.
36. Hamilos DL, Leung DY, Wood R, Cunningham L, Bean DK et al. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. Journal of Allergy and Clinical Immunology 1995; 96(4): 537-544.
37. Milonski J, Zielinska-Blizniewska H, Majsterek I, Przybyłowska-Sygut K, Sitarek P et al. Expression of POSTN, IL-4, and IL-13 in chronic rhinosinusitis with nasal polyps. DNA and Cell Biology 2015; 34(5): 342-349. doi: 10.1089/ dna.2014.2712
38. Miłoński J, Zielińska-Bliźniewska H, Przybyłowska K, Pietkiewicz P, Korzycka-Zaborowska B et al. Significance of CYCLOOXYGENASE-2(COX-2), PERIOSTIN (POSTN) and INTERLEUKIN-4(IL-4) gene expression in the pathogenesis of chronic rhinosinusitis with nasal polyps. European Archives of Otorhinolaryngology 2015; 272(12): 3715-3720. doi: 10.1007/ s00405-014-3481-9
39. Mrowicka M, Zielinska-Blizniewska H, Milonski J, Majsterek I, Olszewski J. Association of IL1β and IL4 gene polymorphisms with nasal polyps in a Polish population. Molecular Biology Reports 2014; 41(7): 4653-4658. doi: 10.1007/s11033-014- 3336-x
40. Zhang ML, Ni PH, Cai CP, Chen NJ, Wang SL. Association of susceptibility to chronic rhinosinusitis with genetic polymorphisms of IL-4 and IL-10 (in Chinese with an English abstract). Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2012; 47(3): 212-217.
41. Park SK, Heo KW, Jung H, Yea SS, Yang YI. Expression of cyclooxygenase-2 and 5-lipoxygenase in nasal polyps associated with interleukin-4 promoter polymorphism -590. Otolaryngology–Head and Neck Surgery 2006; 135(6): 928- 932.
42. Yea SS, Yang YI, Park SK, Jang WH, Lee SS et al. Interleukin-4 C-590T polymorphism is associated with protection against nasal polyps in a Korean population. American Journal of Rhinology 2006; 20(5): 550-553.
43. Basol N, Celik A, Karakus N, Ozturk SD, Yigit S. The evaluation of angiotensin-converting enzyme (ACE) gene I/D and IL-4 gene intron 3 VNTR polymorphisms in coronary artery disease. In Vivo 2014; 28(5): 983-987.
44. Yigit S, Inanir A, Tekcan A, Tural E, Ozturk GT et al. Significant association of interleukin-4 gene intron 3 VNTR polymorphism with susceptibility to knee osteoarthritis. Gene 2014; 537(1): 6-9. doi: 10.1016/j.gene.2013.12.060
45. Kalkan G, Karakus N, Baş Y, Takçı Z, Ozuğuz P et al. The association between Interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in a Turkish population. Gene 2013; 25527(2): 565-569. doi: 10.1016/j. gene.2013.05.086
46. Basol N, Inanir A, Yigit S, Karakus N, Kaya SU. High association of IL-4 gene intron 3 VNTR polymorphism with diabetic peripheral neuropathy. Journal of Molecular Neuroscience 2013; 51(2): 437-441. doi:10.1007/s12031-013-0048-y
47. Kalkan G, Yigit S, Karakus N, Baş Y, Seçkin HY. Association between interleukin 4 gene intron 3 VNTR polymorphism and recurrent aphthous stomatitis in a cohort of Turkish patients. Gene 2013; 527(1): 207-210. doi: 10.1016/j.gene.2013.05.053
48. Karakus N, Yigit S, Kurt GS, Cevik B, Demir O et al. Association of interleukin (IL)-4 gene intron 3 VNTR polymorphism with multiple sclerosis in Turkish population. Human Immunology 2013; 74(9): 1157-1160. doi: 10.1016/j.humimm.2013.05.011
49. Inanir A, Tural S, Yigit S, Kalkan G, Pancar GS et al. Association of IL-4 gene VNTR variant with deep venous thrombosis in Behçet’s disease and its effect on ocular involvement. Molecular Vision 2013; 19: 675-683.
50. Makhlouf MM, Abd Elhamid SM. Expression of IL4 (VNTR intron 3) and IL10 (-627) genes polymorphisms in childhood immune thrombocytopenic purpura. Journal of Laboratory Medicine 2014; 45(3): 211-219. doi: 10.1309/ LMB0QC5T1RXTTRZQ
51. Birbian N, Singh J, Jindal SK, Sobti RC. High risk association of IL-4 VNTR polymorphism with asthma in a North Indian population. Cytokine 2014; 66(1): 87-94. doi: 10.1016/j. cyto.2014.01.002
52. Pérez-Suárez TG, Gutiérrez-Robledo LM, Ávila-Funes JA, Acosta JL, Escamilla-Tilch M et al. VNTR polymorphisms of the IL-4 and IL-1RN genes and their relationship with frailty syndrome in Mexican community-dwelling elderly. Aging Clinical and Experimental Research 2016; 28(5): 823-832. doi: 10.1007/s40520-015-0503-4
53. Bid HK, Konwar R, Agrawal CG, Banerjee M. Association of IL-4 and IL-1RN (receptor antagonist) gene variants and the risk of type 2 diabetes mellitus: a study in the north Indian population. Indian Journal of Medical Sciences 2008; 62(7): 259-266.